WebinarsNew
Deep DiveNew
Explore Business Standard
The National Medical Commission has proposed a centrally generated unique identification number for every registered medical practitioner, which would allow doctors to practise anywhere in the country without obtaining a fresh registration or licence. The proposal is part of the draft Registration of Medical Practitioners and Licence to Practice Medicine (Amendment) Regulations, 2026, notified by the Commission on August 11. Under the proposed framework, once a person or a foreign medical graduate is registered in the state medical register, the Ethics and Medical Registration Board (EMRB) of the National Medical Commission (NMC) would centrally generate a Unique Identification (UID) number. The UID would grant the practitioner registration in the National Medical Register (NMR) and eligibility to practise medicine anywhere in India. The draft specifically states that the UID would be generated after registration in the state medical register, "thereby granting the practitioner, .
The IIT Kharagpur has signed an MoU with the Variable Energy Cyclotron Centre (VECC) and the Chittaranjan National Cancer Institute (CNCI) to launch MSc programmes in nuclear medicine and medical physics. This collaboration aims to strengthen national capacity for skilled human resources in nuclear medicine and medical physics, which are critical to cancer diagnosis, treatment, and advanced clinical research, an IIT KGP spokesperson said Saturday. The programmes will be jointly conducted by IIT Kharagpur, CNCI, and VECC, with student admissions through the Joint Admission Test for Master's (JAM). The MSc programmes will be offered by the School of Medical Science and Technology (SMST) at IIT Kharagpur, starting with the academic session 2026-27. The MoU was signed by IIT Kharagpur Director Suman Chakraborty, CNCI Director Dr Jayanta Chakrabarti, and VECC Director Sumit Som on Friday, marking the beginning of a significant academic collaboration among three 'Institutes of National
BJP MP K Laxman on Thursday urged the government to ensure transparent and standardised medical billing, as he raised concerns over "exploitation practices" by private hospitals. Raising the issue in the Zero Hour in the Rajya Sabha, Laxman said in the absence of norms, many families are pushed into hardship due to medical bills. "There is a rise in exploitative practices by certain private corporate hospitals. Reports from patients, civil society and consumer bodies point to a disturbing pattern of unnecessary diagnostic tests, unwanted prolonged hospital stays with no clinical justification, and opaque billing processes," Laxman said. "Absence of transparent norms leaves people with little choice, pushing many families into hardship. Reports highlight they charge Rs 1,500 to Rs 2,000 as OPD, which is not covered under schemes like Ayushman Bharat," he said. The BJP MP urged the government to take steps to ensure transparent billing. "I urge the government to ensure transparent .
Hyderabad-based biotechnology company BioVaram on Thursday said it has signed a MoU with Japan's Teijin Limited to collaborate on expanding usage of Regenerative Medicine products and Implantable medical devices in Japan and India. BioVaram, the University of Hyderabad incubated startup, is the brand name of the UR Advanced Therapeutics Pvt Ltd (URAT), a release said. The collaboration aims to expand the reach of Teijin Group's implantable medical devices and regenerative medicine products in India, while also introducing BioVaram's advanced product portfolio to the Japanese market, it said. "Under the terms of the agreement, Teijin and BioVaram will explore the regulatory approval and commercialisation of SYNFOLIUM?, a cardiovascular repair patch by Teijin Medical Technologies Co, Ltd, in India," it said. The collaboration will open up opportunities for expanding use of Japan Tissue Engineering Co, Ltd's (part of the Teijin Group) regenerative medicine products in India. The ...
The South-South collaboration remains a priority through joint projects and capacity building to ensure that the region benefits from each other's expertise, ICMR Director General Dr Rajiv Bahl said, emphasising that "science and research must serve people directly". He made the remarks at the concluding day of the two-day regional meeting titled "Health Research and Innovations in Public Health: Exchange of Good Practices across RESEARCH Platform", organised by the Indian council of Medical Research (ICMR). The event, held at the Sushma Swaraj Bhawan, brought together senior representatives from Nepal, Sri Lanka, Bhutan and Timor-Leste to deliberate on strengthening health-research systems, facilitate the exchange of good practices and promote cross-border collaboration in South and Southeast Asia. The meeting marked an important milestone in fostering collaboration across South and Southeast Asia to ensure that health research directly informs policy, addresses regional priorities